Uterine fibroids


Published on

A power point presentation on Fibroids

Published in: Health & Medicine
  • Be the first to comment

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Uterine fibroids

  1. 1. Uterine fibroids
  2. 2. Uterine fibroids• Most common tumors of the female genital tract• Commonest cause of Hysterectomy
  3. 3. Uterine fibroids• Most common benign tumor of the female genital tract• Risk factors- ethnicity, nulliparity, genetics and hormonal factors, Obesity
  4. 4. • Heterogeneity in behavior of fibroids and the symptoms attributable to them
  5. 5. Regulation of the growth of uterine fibroids• Estrogen and progesterone dependent• Increased estrogen receptor gene expression in uterine fibroids• Role of apoptosis
  6. 6. Clinical presentation of fibroids• Peaks in the peri menopausal years and declines after the menopause• More than 50% of myomas are asymptomatic
  7. 7. Common symptoms• Abnormal uterine bleeding• Pelvic pressure symptoms & discomfort
  8. 8. ABNORMAL VAGINAL BLEEDING• Most characteristic of myomas is menorrhagia• Increased endometrial surface area• Increased vascularity of the uterus Interference with normal uterine contractility• Endometrial ulceration over submucous leiomyomas, which could also cause intermenstrual bleeding• Compression of venous plexus within the myometrium
  9. 9. PELVIC PAIN• Fibroids located posteriorly- lower back pain• Anterior tumours may cause bladder discomfort and increased urinary frequency.• Leiomyomas that fill the pelvis may cause difficulty with urination, defaecation and dyspareunia Broad ligament may cause unilateral lowerabdominal pain or sciatic nerve pain
  10. 10. Acute pain• Torsion• Red degeneration-localized tenderness over the fibroid, mild leukocytosis, pyrexia, and nausea and vomiting
  11. 11. • Pain however is not a common feature of fibroids• Rule out other conditions like endometriosis, adenomyosis
  12. 12. PELVIC MASS SYMPTOMS• May simply put on weight• Bladder capacity reduced- increased frequency• Retention of urine
  13. 13. REPRODUCTIVE DYSFUNCTION• Infertility• obstruct the tubal ostia• Submucosal fibroids and intramural fibroids distorting the uterine cavity• Myomectomy, whether by the conventional abdominal route or laparoscopically, appears to be associated with improved pregnancy rates• Bulletti C, Ziegler D, Levi Setti P et al. Myomas, pregnancy outcome, and in vitro fertilization. Ann NY Acad Sci 2004; 1034: 84–92.
  14. 14. Fibroids and Infertility• Despite the lack of evidence from randomized studies it does appear that surgical intervention for uterine fibroids does increase pregnancy rates• 50% of women conceiving following myomectomy for fibroid-associated infertility.• Palomba S, Zupi E, Russo T et al. A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: short-term outcomes. Fertil Steril 2007; 88: 942–951
  15. 15. Abortion and Myoma• Submucus or myomas distorting the cavity• Multiple myomas Miscarriage rates fall after myomectomy
  16. 16. FIBROIDS AND THEIR IMPACT ON ANTENATAL COMPLICATIONS OF PREGNANCY AND LABOUR• Have been linked to a number of complications• Positive association between the presence of fibroids and malpresentations such as breech presentation, operative delivery and caesarean section - demonstrated repeatedly
  17. 17. Fibroids and pregnancy• Only few fibroids grow(20%) in pregnancy, growth limited to first trimester• Submucus fibroid – abortion• Weak association with preterm labour• Placenta previa weak association• PPH weak association
  18. 18. POSTPARTUM SEQUELAE OF FIBROIDS• Ischaemic degenerationanaerobic infection• Fibroid tissue may be expelled
  19. 19. RARE ASSOCIATIONS• Myomas may be parasitic• secondary polycythaemia• Ascites• Benign metastasizing myomas• Intravenous leiomyomatosis• Leiomyomatosis peritonealis disseminata
  20. 20. MALIGNANCY• leiomyosarcomas arise de novo• 0.13 and 0.29%
  21. 21. Asymptomatic uterine fibroids• Even with symptoms such as infertility, pelvic pain and abnormal bleeding, it is not always possible to be certain that a given myoma is not simply an innocent bystander• 40% by 35 years of age and almost 70% by 50 years of age• 50% of fibroids are asymptomatic
  22. 22. Asymptomatic fibroid• Why some cause symptoms and others don’t?• Is there is any possibility of malignancy?• Whether they need a hysterectomy?• Whether the fibroid(s) will compromise fertility and pregnancy outcomes?• Whether the fibroids are likely to grow, and if there is any therapy to stop them Growing?• Does waiting and watching will cause any harm?
  23. 23. Fibroid – C section• Fibroids should be left well alone at the time of caesarean section
  24. 24. The Management of Uterine FibroidsWorking Party of the New Zealand Guidelines Group• Size less than 16 weeks observe after excluding other pathology• Concern about possible complications related to fibroids in pregnancy is not an indication for myomectomy, except in women who have experienced a previous pregnancy with complications related to these fibroids• Trial of conception for 6 months
  25. 25. The Management of Uterine FibroidsWorking Party of the New Zealand Guidelines Group• Myomas that disturb the cavity may be removed before IVF
  26. 26. Imaging• Aim• Determination of the number, size and position ofmyomata, as well as the dimensions of the uterus• To rule out other pathology
  27. 27. USG• Preferred method• Well demarcated mass with in myometrium• May be hypo/hyper• Adenomyosis.-minimal or no mass effect elliptical shape of uterus maintained• Colour doppler diffuse vascularity in adneomyosis
  28. 28. USG• Both TAS and TVS• TVS endometrium small fibroids• Sonohysterography submucus myomas
  29. 29. MRI• Submucus myomas• Cervical myomas
  30. 30. Rule out• Leiomyosarcoma no sharp margins• Sample endometrium if ET > 15 mm in premenopausal woman• Adnexal masses may be confused with subserosal pedunculated leiomyomata – CT MRI Laparoscopy
  31. 31. Medical management of fibroids• Fibroid growth is hormone dependent• Medical treatments mainly involve hormonal manipulations
  32. 32. Indications for medical therapy• Treatment for temporary relief of symptoms for short period• Pre-operative adjunct to reduce the size of fibroids, to control bleeding and to improve haemoglobin levels
  33. 33. GnRH analogues• Symptoms of estrogen deficiency limit the standard use of GnRHa to 6 months• Fibroids returning to their original size or even enlarging more rapidly upon cessation of therapy• Add back -tibolone, raloxifene, progestogens alone, oestrogens alone, and combined oestrogens and progestogens
  34. 34. Preoperative use of GnRHa• GnRHa render surgical planes less distinct, making enucleation difficult• large and multiple fibroids (level of the umbilicus and beyond) responds poorly• GnRHa increases the risk of recurrence since smaller fibroids regress and missed• Not cost effective (Vassopressin cheaper)
  35. 35. GnRH analogues• Only indication of GnRH analogues is to reduce the size of submucus myoma before hysteroscopic myomectomy
  36. 36. GNRH ANTAGONISTS• Not studied well
  37. 37. SELECTIVE OESTROGEN RECEPTOR MODULATORS• Insufficient evidence to conclude that SERMs reduce the size of fibroids or improve clinical outcomes in premenopausal women
  38. 38. AROMATASE INHIBITORS• Anastrozole• Confined to case reports• Not very effective in premenopausal women• long-term use and risk of bone loss and fracture risk
  39. 39. LEVONORGESTEROL INTRA-UTERINE DEVICE• Reduction in menstural blood loss& symptoms• Not suitable fro sunmucus and large myomas
  40. 40. ANTIPROGESTERONESNo change in bone mineral density5 or 10 mg/day for 1 year
  41. 41. Myomectomy• Sole purpose of myomectomy is to improve fertility• In 2/3 of women who have had myomectomy menstrual symptoms does not subside
  42. 42. Conventional myomectomy• Contrary to popular belief, this is an operation which demands considerable skill if it is to yield optimal outcomes
  43. 43. Pre-operative assessment• USG , MRI for cervical fibroids• Submucus fibroids hysteroscopy
  44. 44. Preoperative assessment• Small risk of needing to progress to hysterectomy• Pre-existing anaemia should be corrected
  45. 45. Intra-operative measures and surgical technique• Transverse incision• Pull sow with myoma screw
  46. 46. Uterus is “bloody” organ
  47. 47. Physical occlusion of blood flow• Boneys clamp
  48. 48. • Single tourniquet around uterine A the cervix to achieve haemostasis• Occlude the ovarian arteries, and one to occlude the uterine arteries
  49. 49. • Preoperative Uterine A Embolisation?
  50. 50. Preop GnRH• Small fibroids may be missed• Planes unclear Not generally recommended Huge fibroids respond poorly Not cost effective Planes destroyed, increase the risk of recurrenceOnly indication may be sub mucus fibroid, where itmay facilitate an hysteroscopic removal
  51. 51. • 1 g tranexamic acid by slow intravenous infusion at the time of induction of anaesthesia• Dilute 20 units vasopressin in 100 mL normal saline• Avoid injection directly into blood vessels
  52. 52. • Intravaginal misoprostol 400 microgram
  53. 53. Vasopressin vs. physical occlusion• o difference in operative blood loss, operative time, postoperative febrile morbidity, preoperative, and postoperative hematocrits or transfusion rates.• Ginsburg ES, Benson CB, Garfield JM, Gleason RE & FreidmanAJ (1993). The effect of operative technique and uterine size on blood loss during myomectomy: a prospective randomized study. FertilSteril 60:956-62
  54. 54. Uterine incision• Single, anterior, midline vertical incision• multiple incisions are minimum. The incision should extendthrough the serosa,myometrium and into thecapsule of the leiomyoma
  55. 55. • “Stay with in the pseudocapsule and myoma”
  56. 56. • Every effort should be made to remove all visible and/or palpable myomas• If the endometrial cavity is breached, the repair it with fine interrupted extramural sutures using 2/0 vicryl
  57. 57. Closure• 1/0 vicryl sutures• Interrupted figure of eight sutures
  58. 58. Bonneys hood
  59. 59. Myomas in special locations• Broad ligament myoma• Incise round ligament• Work with in the capsule
  60. 60. Cervical myomas• Real challenge• Accurate location of myoma by MRI• Preoperative GnRH• Central divide UV fold and bisect the Uterus• Posterior myoma-low posterior incision at the back of the uterus
  61. 61. RISKS AND COMPLICATIONS OF CONVENTIONAL MYOMECTOMY• Bleeding• Exceptionally rare to have to resort to hysterectomy• Infectious morbidity is infrequent• Adhesions-meticulous haemostasis• Use of minimally reactive absorbable sutures; copious irrigation at the time of myomectomy; paying attention to suturing techniques and, possibly, use of intraperitoneal drains
  62. 62. Risk of recurrence after myomectomy• 40% and 50%• Risk decreased with• Single myoma• Pregnancy
  63. 63. Endoscopic management of uterine fibroids• Less adhesions, rates of conception, miscarriage, preterm birth and caesarean section were similarSeracchioli R, Rossi S, Govoni F et al. Fertility and obstetricoutcome after laparoscopic myomectomy of large fibroid: arandomized comparison with abdominal myomectomy. HumReprod 2000; 15: 2663–2668.
  64. 64. Lap myomectomy• Less than 15 cm(6-10cm)• 3 fiborids less than 5 cm• Surgeon loses the ability to palpate uterine tissue to detect smaller myomas• Incidence of rupture uterus in pregnancy similar with open myomectomy
  65. 65. Lap myomectomy
  66. 66. Lap myomectomy• Not adhesion free• But incidence of adhesion is less compared to laparotomy• Conversion rate to open myomectomy 5%
  67. 67. • Fibroid myolysis
  68. 68. LAPAROSCOPIC THERMOMYOLYSIS• Rupture• Adhesion
  69. 69. Radiological treatment of symptomatic uterine fibroids• Uterine artery embolisation• Menorrhagia is controlled in 85–95% of patients, and bulk-related symptoms are controlled in 70–90% of patients• Sub mucus forbids are better treated with hysteroscopic resection
  70. 70. UAE and Fertility• Premature menopause induced by UAE has been estimated at up to 25% in women above the age of 45 years and 1% in younger women• Procedure should not be offered routinely to women who wish to preserve their reproductive potential• Ahmad A, Qadan L, Hassan N et al. Uterine artery embolization treatment of uterine fibroids: effect on ovarian function in younger women. J Vasc Interv Radiol 2002; 13: 1017–1020
  71. 71. UAE and fertility• Concerns of preterm labour,abnormal placentation• Carpenter TT & Walker WJ. Pregnancy following uterine artery embolisation for symptomatic fibroids: a series of 26 completed pregnancies. Br J Obstet Gynaecol 2005; 112: 321–325
  72. 72. Uterine artery embolization as a surgical adjuvant• Not recommended before myomectomy chances of rupture• May help to convert midline incision to transverse incision in hysterectomy
  73. 73. Complications• Chronic vaginal discharge 4-7% of patients• Fibroid extrusion through the vagina• Premature ovarian failure or severe pelvic sepsis• Postembolization syndrome
  74. 74. Edwards RD et al UAE vs Surgery for symptomatic fibroid N E J M 2007:356(4):360-370• 13% had intervention after 1 year in the UAE group
  75. 75. REST trial (Randomized controlled trial of Embolization vs Surgical Treatment for fibroids• Need for re-intervention for persistent symptoms at around 10% at 1 year• Complication rates similar
  76. 76. UAE• Recommended by the National Institute for Clincial Excellence (NICE) in the UK as an alternative therapy to hysterectomy
  77. 77. Long term outcome of UAE• On 5-7 year follow 12-20% needs intervention• Spies JB, Bruno J, Czeyda-Pommersheim F et al. Long-term outcome of uterine artery embolizationof leiomyomata. Obstet Gynecol 2005; 106: 933–939.• Katsumori T, Kasahara T & Akazawa K. Long-term outcomes of uterine artery embolization using gelatin sponge particles alone for symptomatic fibroids. AJR Am J Roentgenol 2006; 186: 848–854• Walker WJ & Barton-Smith P. Long-term follow up of uterine artery embolisation – an effective alternative in the treatment of fibroids. Br J Obstet Gynaecol 2006; 113: 464– 468
  78. 78. Magnetic-resonance-guided focused ultrasound surgery• Causes heat within the tissues and causes coagulative necrosis of tissue• Symptomatic uterine fibroids and who have no desire for future pregnancy• Volume reduction is less than UAE Mean time in return to normal activity 1 day
  79. 79. Laparoscopic uterine artery occlusion• 50% reduction in menorhaghia• Uterine volume was reduced by 35-40%
  80. 80. Hysterectomy• The need to treat symptoms—abnormal uterine bleeding, pelvic pain, or pelvic pressure• “Rapid” uterine enlargement , ureteral compression, or uterine growth after menopause• ?Based on size > 12 weeks
  81. 81. Hysterectomy-Choice of Approach: Abdominal, Vaginal, or Laparoscopic• Fibroids up to 12 weeks VAGINAL• 12-16 weeks VH,LAVH>TLH• > 16 weeks Abdominal Hystercetomy• Lateral enlargement of uterus -TLH difficult
  82. 82. Hysterectomy for cervical fibroids• Anterior• Posterior• Central-‘the lantern on the top of St Paul’s’• Pseudocervical fibroid• Lateral• Hysterectomy cant be done until myoma is removed by myomectomy
  83. 83. Cervical fiborid• ??GnRH analogues• Destroy planes and elimines one of the very few ‘godsends’
  84. 84. Hysterectomy for an anterior cervical myoma
  85. 85. Central cervical myoma Hemisection
  86. 86. Posterior myoma
  87. 87. CONTRACEPTIVE OPTIONS IN THE PRESENCE OF FIBROIDS• OCP,POP,DMPA ARE OPTIONS• LNG-IUS-effective in controlling bleeding,may reduce the size of fibroids• Contraceptive efficacy of LNG IUS in women with fibroids, with or without menorrhagia, appears to remain intact
  88. 88. References1) Uterine fibroids- Best Practice & ResearchClinical Obstetrics and Gynaecology Vol. 22, No.4,20082) Malcolm G. Munro Uterine Leiomyomas,Current Concepts:Pathogenesis, Impact onReproductive Health and Medical, Procedural,and Surgical Management Obstet Gynecol ClinN Am 38 (2011) 703–731
  89. 89. 3) Uterine myoma Obstetrics Gynaecologyclinics of north America Volume 33, Issue 1(March 2006)4) Te Lindes operative Gynaecology Rock, JohnA.; Jones, Howard W 10th edition LippincottWilliams & Wilkins5) Bonney’s gynaecological surgery.—10th ed.John M. Monaghan,Tito Lopes, Raj Naik.Blackwell Science Ltd
  90. 90. • 6) Togas Tulandi Uterine fibroids Embolisation and other treatment 2003 Cambridge univeristy press